Metraipolis › archive › dc_49abd239cc76

Frailty and [177Lu]Lu-PSMA-617 therapy: tools and strategies for older men with metastatic castration-resistant prostate cancer — Europe PMC PMID:42707638

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42707638
DOI: 10.7150/thno.131438
License (as archived): solo-consultazione
Archived: 2026-10-17T08:25:02.482Z
SHA-256 of the archived text: d75fe735864b1c124a3e958591ed7df20b6815d4d0a9ac408d65053696e3a7c5
Stable URL of this page: https://metraipolis.com/documento/dc_49abd239cc76

How to cite

Frailty and [177Lu]Lu-PSMA-617 therapy: tools and strategies for older men with metastatic castration-resistant prostate cancer — Europe PMC PMID:42707638 — Europe PMC (en), https://europepmc.org/article/MED/42707638 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49abd239cc76 (Metraipolis archive dc_49abd239cc76, sha256 d75fe735864b1c124a3e958591ed7df20b6815d4d0a9ac408d65053696e3a7c5)

BibTeX

@misc{dc49abd239cc76,
  title = {Frailty and [177Lu]Lu-PSMA-617 therapy: tools and strategies for older men with metastatic castration-resistant prostate cancer — Europe PMC PMID:42707638},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42707638},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49abd239cc76; sha256 d75fe735864b1c124a3e958591ed7df20b6815d4d0a9ac408d65053696e3a7c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42707638. Agents can read the archived copy with the MCP tool read_document.